It has become standard practice to assess the effects of new antisecretory agents by measuring gastric acidity over 24 hours.'-" Famotidine is a new H2-receptor antagonist which is more potent than ranitidine (approximately eight times weight for weight).'"'5 Early clinical results with famotidine show it to be as effective as either cimetidine or ranitidine. h 7 No previous study, however, has compared the effects of single doses of these three drugs on 24 hour gastric acidity in a double blind study of adequate size although in one study of seven subjects, famotidine 40 mg appeared more effective in reducing nocturnal acidity than ranitidine 300 mg.x
We have done repeated studies of 24 hour acidity in 30 volunteers in order to be confident that observed differences were real.
Methods

SUBJECTS
Thirty healthy volunteers (15 women, 15 men) each underwent four separate 24 hour studies at least one week apart in Berlin. Half the subjects were nonsmokers and the mean age was 25.5 years (19-39 range) . Clinical, biochemical and haematological parameters were normal before study and all subjects gave informed consent. Ethical committee approval for the study was obtained before the start. Subjects took apparently identical capsules containing cimetidine 800 mg, ranitidine 300 mg, famotidine 40 mg or placebo in random order at 1900 h after the evening meal. No other drugs were allowed during the study which compared single doses of the H2-receptor antagonists.
The technique used for the measurement of 24 hour acidity has been previously described.1" 2"1 Normal fixed diets were used unrestricted after the first four hours. Drugs 14 15 Time (h) Median pH during the four treatments was compared for the following predefined time periods, 24 hours, night (2200-0600), early morning (0600-1000), late morning (1000-1200) and afternoon (1200-1500). Wilcoxon's signed rank tests were applied with correction of significance for multiple testing when appropriate. Box-whisker-plots ofnight time acidity (2200-0600) during all treatments. All drugs produced significant inhibition ofacidity compared with placebo (p<0.0005) and ranitidine andfamotidine had significantly greater effects than cimetidine (p<0005).
Results
The median pH profile of the 30 subjects are shown for the four treatments in Figure 1 . All H2-receptor antagonists inhibited 24 Figures 3 and 4 . All drugs decreased acidity compared with placebo but statistical testing ofthese differences was not done as it had not been planned in the protocol. placebo, and decreased after cimetidine 800 mg to 10 mmol/l (15-8-6-6), after ranitidine 300 mg to 3-2 mmol/l (5.6-1-0) and after famotidine 40 mg to 2-5 mmol/l (5-6-1-0). The effect of cimetidine was significantly less than either ranitidine or famotidine (p<0.001), but there was no significant difference between famotidine and ranitidine during any predefined time period. Box-whisker-plots showing the distribution, median, interquartile ranges and means for the evening (Fig. 2), night (Fig. 3) and the early morning acidity (Fig. 4) are shown. All three drugs significantly decreased gastric acidity during the latter two periods compared with placebo (p<0-005). During the late morning (1000-1200) median pH was 1-5 with placebo, 1-3 with cimetidine (NS), 1-5 with ranitidine (NS) and, after a consistent response with famotidine, was 1-7 (significant compared with placebo (p<0-005)). No significant inhibition of acidity was found with any drug during the afternoon. The pH frequency distribution curves (Fig. 5) clearly show that the overall effects of ranitidine and famotidine are indistinguishable.
Discussion
Continuous intragastric pH monitoring is becoming more popular as an accurate assessment of gastric pH over prolonged periods. The equipment and technique used here have been validated' " and are able to detect changes of pH during predefined time periods of 0-1 unit or greater.2 In common with other methods where only pH is measured the volume of gastric secretion cannot be assessed and information about peptic activity and bile salt concentrations is not collected. Important information about the effects of antisecretory drugs has previously been successfully collected by this and other techniques assessing only intragastric pH. '" 19 1 This study confirms that famotidine and ranitidine are more potent inhibitors of gastric acidity than cimetidine. In the recommended dosages for clinical use, ranitidine and famotidine decrease 24 hour intragastric acidity to a similar degree. We have not been able to confirm the findings of a small study which suggested that famotidine 40 mg was more effective than ranitidine 300 mg during the night when taken in the early evening. ' 
